Functional analysis of six human aryl hydrocarbon receptor variants in human breast cancer and mouse hepatoma cell lines

Toxicology

Volumn 277, Issue 1-3, 2010, Pages 59-65

  Celius, Trine ^a   Matthews, Jason ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

2,3,7,8 Tetrachlorodibenzo p dioxin; Aryl hydrocarbon receptor; Cytochrome P450 1A1; Gene regulation; Single nucleotide polymorphisms

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; CYP1B1 PROTEIN, HUMAN; CYP1B1 PROTEIN, MOUSE; CYTOCHROME P450; UNSPECIFIC MONOOXYGENASE;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME REGULATION; GENE ACTIVITY; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HEPATOMA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REPORTER GENE; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; COMPARATIVE STUDY; DRUG EFFECTS; EXPERIMENTAL LIVER NEOPLASM; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL CARCINOMA; METABOLISM; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; TOXICITY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION REGULATION; GENETIC VARIATION; HUMANS; LIVER NEOPLASMS, EXPERIMENTAL; MICE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ARYL HYDROCARBON; TETRACHLORODIBENZODIOXIN; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP1B1;

EID: 77957879217     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.08.015     Document Type: Article

References (37)

1. Anttila S., Tuominen P., Hirvonen A., Nurminen M., Karjalainen A., Hankinson O., Elovaara E. CYP1A1 levels in lung tissue of tobacco smokers and polymorphisms of CYP1A1 and aromatic hydrocarbon receptor. Pharmacogenetics 2001, 11:501-509.
2. Berwick M., Matullo G., Song Y.S., Guarrera S., Dominguez G., Orlow I., Walker M., Vineis P. Association between aryl hydrocarbon receptor genotype and survival in soft tissue sarcoma. J. Clin. Oncol. 2004, 22:3997-4001.
3. Birnbaum L.S., McDonald M.M., Blair P.C., Clark A.M., Harris M.W. Differential toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in C57BL/6J mice congenic at the Ah Locus. Fundam. Appl. Toxicol. 1990, 15:186-200.
4. Chen Y., Bai Y., Yuan J., Chen W., Sun J., Wang H., Liang H., Guo L., Yang X., Tan H., Su Y., Wei Q., Wu T. Association of polymorphisms in AhR, CYP1A1, GSTM1, and GSTT1 genes with levels of DNA damage in peripheral blood lymphocytes among coke-oven workers. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1703-1707.
5. Ciolino H.P., Dankwah M., Yeh G.C. Resistance of MCF-7 cells to dimethylbenz(a)anthracene-induced apoptosis is due to reduced CYP1A1 expression. Int. J. Oncol. 2002, 21:385-391.
6. Connor K.T., Aylward L.L. Human response to dioxin: aryl hydrocarbon receptor (AhR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR. J. Toxicol. Environ. Health B: Crit. Rev. 2006, 9:147-171.
7. Fernandez-Salguero P.M., Hilbert D.M., Rudikoff S., Ward J.M., Gonzalez F.J. Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicol. Appl. Pharmacol. 1996, 140:173-179.
8. Fernandez-Salguero P., Pineau T., Hilbert D.M., McPhail T., Lee S.S., Kimura S., Nebert D.W., Rudikoff S., Ward J.M., Gonzalez F.J. Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science 1995, 268:722-726.
9. Flaveny C.A., Murray I.A., Chiaro C.R., Perdew G.H. Ligand selectivity and gene regulation by the human aryl hydrocarbon receptor in transgenic mice. Mol. Pharmacol. 2009, 75:1412-1420.
10. Hahn M.E. The aryl hydrocarbon receptor: a comparative perspective. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol. 1998, 121:23-53.
11. Hahn M.E. Aryl hydrocarbon receptors: diversity and evolution. Chem. Biol. Interact. 2002, 141:131-160.
12. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 1995, 35:307-340.
13. Harper P.A., Wong J.Y., Lam M.S., Okey A.B. Polymorphisms in the human AH receptor. Chem. Biol. Interact. 2002, 141:161-187.
14. Hestermann E.V., Stegeman J.J., Hahn M.E. Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency. Toxicol. Appl. Pharmacol. 2000, 168:160-172.
15. Kawajiri K., Watanabe J., Eguchi H., Nakachi K., Kiyohara C., Hayashi S. Polymorphisms of human Ah receptor gene are not involved in lung cancer. Pharmacogenetics 1995, 5:151-158.
16. Koyano S., Saito Y., Fukushima-Uesaka H., Ishida S., Ozawa S., Kamatani N., Minami H., Ohtsu A., Hamaguchi T., Shirao K., Yoshida T., Saijo N., Jinno H., Sawada J. Functional analysis of six human aryl hydrocarbon receptor variants in a Japanese population. Drug Metab. Dispos. 2005, 33:1254-1260.
17. Le Marchand L., Donlon T., Kolonel L.N., Henderson B.E., Wilkens L.R. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1998-2003.
18. Lin G.F., Ma Q.W., Zhang D.S., Zha Y.L., Lou K.J., Shen J.H. Polymorphism of alpha-estrogen receptor and aryl hydrocarbon receptor genes in dementia patients in Shanghai suburb. Acta Pharmacol. Sin. 2003, 24:651-656.
19. Long J.R., Cai Q., Shu X.O., Cai H., Gao Y.T., Zheng W. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival. Pharmacogenet. Genomics 2007, 17:331-338.
20. MacPherson L., Lo R., Ahmed S., Pansoy A., Matthews J. Activation function 2 mediates dioxin-induced recruitment of estrogen receptor alpha to CYP1A1 and CYP1B1. Biochem. Biophys. Res. Commun. 2009, 385:263-268.
21. Matthews J., Wihlen B., Heldring N., MacPherson L., Helguero L., Treuter E., Haldosen L.A., Gustafsson J.A. Co-planar 3,3',4,4',5-pentachlorinated biphenyl and non-co-planar 2,2',4,6,6'-pentachlorinated biphenyl differentially induce recruitment of oestrogen receptor alpha to aryl hydrocarbon receptor target genes. Biochem. J. 2007, 406:343-353.
22. Micka J., Milatovich A., Menon A., Grabowski G.A., Puga A., Nebert D.W. Human Ah receptor (AHR) gene: localization to 7p15 and suggestive correlation of polymorphism with CYP1A1 inducibility. Pharmacogenetics 1997, 7:95-101.
23. Moffat I.D., Boutros P.C., Chen H., Okey A.B., Pohjanvirta R. Aryl hydrocarbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities. BMC Genomics 2010, 11:263.
24. Ng C.H., Janoo-Gilani R., Sipahimalani P., Gallagher R.P., Gascoyne R.D., Connors J.M., Weber J.P., Lai A.S., Leach S., Le N.D., Brooks-Wilson A.R., Spinelli J.J. Interaction between organochlorines and the AHR gene, and risk of non-Hodgkin lymphoma. Cancer Causes Control 2010, 21:11-22.
25. Pandini A., Soshilov A.A., Song Y., Zhao J., Bonati L., Denison M.S. Detection of the TCDD binding-fingerprint within the Ah receptor ligand binding domain by structurally driven mutagenesis and functional analysis. Biochemistry 2009, 48:5972-5983.
26. Pohjanvirta R., Wong J.M., Li W., Harper P.A., Tuomisto J., Okey A.B. Point mutation in intron sequence causes altered carboxyl-terminal structure in the aryl hydrocarbon receptor of the most 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant rat strain. Mol. Pharmacol. 1998, 54:86-93.
27. Poland A., Palen D., Glover E. Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol. Pharmacol. 1994, 46:915-921.
28. Porteus M.H., Carroll D. Gene targeting using zinc finger nucleases. Nat. Biotechnol. 2005, 23:967-973.
29. Roblin S., Okey A.B., Harper P.A. AH receptor antagonist inhibits constitutive CYP1A1 and CYP1B1 expression in rat BP8 cells. Biochem. Biophys. Res. Commun. 2004, 317:142-148.
30. Rowlands C.J., Staskal D.F., Gollapudi B., Budinsky R. The human AHR: identification of single nucleotide polymorphisms from six ethnic populations. Pharmacogenet. Genomics 2010, 20:283-290.
31. Sangrajrang S., Sato Y., Sakamoto H., Ohnami S., Laird N.M., Khuhaprema T., Brennan P., Boffetta P., Yoshida T. Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int. J. Cancer 2009, 125:837-843.
32. Shin A., Shrubsole M.J., Rice J.M., Cai Q., Doll M.A., Long J., Smalley W.E., Shyr Y., Sinha R., Ness R.M., Hein D.W., Zheng W. Meat intake, heterocyclic amine exposure, and metabolizing enzyme polymorphisms in relation to colorectal polyp risk. Cancer Epidemiol. Biomarkers Prev. 2008, 17:320-329.
33. Smart J., Daly A.K. Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics 2000, 10:11-24.
34. Wanner R., Zober A., Abraham K., Kleffe J., Henz B.M., Wittig B. Polymorphism at codon 554 of the human Ah receptor: different allelic frequencies in Caucasians and Japanese and no correlation with severity of TCDD induced chloracne in chemical workers. Pharmacogenetics 1999, 9:777-780.
35. Wong J.M., Okey A.B., Harper P.A. Human aryl hydrocarbon receptor polymorphisms that result in loss of CYP1A1 induction. Biochem. Biophys. Res. Commun. 2001, 288:990-996.
36. Wong J.M., Harper P.A., Meyer U.A., Bock K.W., Morike K., Lagueux J., Ayotte P., Tyndale R.F., Sellers E.M., Manchester D.K., Okey A.B. Ethnic variability in the allelic distribution of human aryl hydrocarbon receptor codon 554 and assessment of variant receptor function in vitro. Pharmacogenetics 2001, 11:85-94.
37. Zhang D.S., Lin G.F., Ma Q.W., Shen J.H. Nonassociation of aryl hydrocarbon receptor genotypes with susceptibility to bladder cancer in Shanghai population. Acta Pharmacol. Sin. 2002, 23:188-192.